Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5403
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease ; day:16 ; month:12 ; year:2020 ; pages:1-13
Cell death and differentiation ; (16.12.2020), 1-13
- Creator
-
Milanese, Chiara
Gabriels, Sylvia
Barnhoorn, Sander
Cerri, Silvia
Ulusoy, Ayşe
Gornati, S. V.
Wallace, Daniel F.
Blandini, Fabio
Di Monte, Donato A.
Subramaniam, V. Nathan
Mastroberardino, Pier G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41418-020-00698-4
- URN
-
urn:nbn:de:101:1-2021012306110634660753
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Milanese, Chiara
- Gabriels, Sylvia
- Barnhoorn, Sander
- Cerri, Silvia
- Ulusoy, Ayşe
- Gornati, S. V.
- Wallace, Daniel F.
- Blandini, Fabio
- Di Monte, Donato A.
- Subramaniam, V. Nathan
- Mastroberardino, Pier G.
- SpringerLink (Online service)
Other Objects (12)
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model
Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation
Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson’s disease?
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition
Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson’s disease treatment
Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
CtBP Neuroprotective Role in Toxin-Based Parkinson’s Disease Models: From Expression Pattern to Dopaminergic Survival
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model
Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation
Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson’s disease?
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition
Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson’s disease treatment
Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
CtBP Neuroprotective Role in Toxin-Based Parkinson’s Disease Models: From Expression Pattern to Dopaminergic Survival
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease
Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model
Correction: Neuroprotective effects of Shende’an tablet in the Parkinson’s disease model
Safranal exerts a neuroprotective effect on Parkinson’s disease with suppression of NLRP3 inflammation activation
Does 22q11.2 deletion syndrome contribute to the genetic aetiology of Parkinson’s disease?
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson’s disease
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
TMEM106B Knockdown Exhibits a Neuroprotective Effect in Parkinson’s Disease via Decreasing Inflammation and Iron Deposition
Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson’s disease treatment
Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease